Gastroesophageal reflux disease (GERD) is a common problem in the community and in general practice. General practitioners andfamily physicians need to understand patients' reasons for consultation and also be aware ofalarm symptoms suggestive ofserious disease. A primary care management strategy for GERD is proposed, in which the place of endoscopic and other investigations is defined, the role of lifestyle modification discussed, and recommendations for longer-term therapy and management are made.
INTRODUCTION
Most medical contacts take place in general practice and primary care, and most management decisions about gastroesophageal reflux disease (GERD) and reflux-like dyspepsia are taken in the community and in primary care physicians' offices. A primary care management strategy for GERD needs to pay attention to the epidemiological background, including the frequency and distribution of reflux-like symptoms in the community, to the distinctive characteristics of patients presenting in primary care for the first time with reflux symptoms, to the need to make timely, cost-effective diagnostic and management decisions, avoiding unnecessary investigation and referral whenever possible, and to the challenge of providing long-term effective control of symptoms and esophageal damage that is both patient-centered and evidence-based.
REFLUX SYMPTOMS IN THE COMMUNITY
Dyspeptic symptoms of all kinds are very common in the general population. In the United Kingdom the six-month prevalence of dyspepsia in the adult population is in the region of 40 percent [1] [2] . The most recent study, specifically measuring the prevalence of heartburn and reflux-like symptoms in the community [3] , confirms a population prevalence in the region of 40 percent.
There is considerable overlap, demonstrated in the first two of these studies, between ulcer-like and reflux-like symptoms, with 56 percent of the British patients experiencing these symptoms on the same or on different occasions. Talley's group has also pointed out the considerable symptomatic overlap between upper and lower gastrointestinal symptoms in the community. The prevalence of symptoms tends to fall with increasing age, and symptom prevalence is approximately equal in the sexes.
Self-care is the rule for the management of dyspepsia and heartburn; only about 25 percent of these patients ever consult a general practitioner [1] , so that the majority of people with upper abdominal complaints take care of them without entering formal medical care. Two studies documenting the natural history of dyspeptic symptoms suggest that non-consulting patients tend to continue not to consult over significant periods of time [4, 5] .
PRESENTATION IN PRIMARY CARE
What are the factors that turn people into patients? A detailed study of 66 consulting and 69 non-consulting patients with dyspepsia, identified from a community survey, provide some evidence about this [6] . There 
DIAGNOSIS AND EARLY MANAGEMENT
The task of the generalist is to marginalize danger, while that of the specialist is to marginalize uncertainty. In other words, the first task of a general practitioner or family physician, confronted with a patient with ill-defined symptoms, is to make a timely determination of whether these symptoms represent a potentially serious problem for which urgent intervention is required. It is important to remember that only a minority of patients presenting in primary care will have serious disease; while upper gastrointestinal problems account for 4 to 5 percent of the work of a general practitioner Figure 1 . A primary care management strategy. modification in primary care is very few. Dent [10] has emphasized that the relief afforded by modem anti-secretory drugs is seldom achieved by traditional non-drug measures. There is evidence too that physicians infrequently recommend lifestyle modifications in GERD; a recent survey from Virginia [11] reported that less than half of a sample of patients with GERD were given consistent and appropriate lifestyle advice. 
A PRIMARY CARE MANAGEMENT STRATEGY
Despite these reservations and gaps in evidence, it is possible to provide some guidance on the management of GERD in primary care, and a primary care management strategy is outlined in the accompanying figure (Figure 1) .
Patients with predominant heartburn and regurgitation, i.e., with typical symptoms and without alarm symptoms should initially be managed by careful explanation of the likely cause of their symptoms and lifestyle advice where appropriate. If this approach, together with over-thecounter or prescription antacids, results in symptom resolution, patients should be encouraged to self-manage and self-medicate in the future.
If, however, lifestyle advice and simple measures are ineffective -and many patients consulting family physicians will already have tried some of these strategies -empirical therapy (i.e., before evidence has been obtained at endoscopy) with a proton pump inhibitor (PPI) at standard dosage for up to eight weeks can be employed. If this results in resolution of symptoms, there is no need for further investigation at this stage, but if this approach is ineffective or symptoms relapse rapidly, endoscopy is indicated. The endoscopic findings require careful consideration. Microscopic esophagitis is likely to require either on-demand or maintenance therapy, generally with a PPI, although in some patients a "step down" apprQach to a less expensive form of therapy may be feasible. Clearly patients with cancer, or Barratt's esophagus need to be referred for specialist management, involving surgery and/or regular endoscopic surveillance.
Patients with typical GERD symptoms, but in whom endoscopy is negative, represent a particular problem. As many as 40 percent of patients with significant GERD will have normal endoscopies, and so negative findings at initial endoscopy do not exclude the diagnosis of GERD.
The role of pH monitoring, however, remains controversial. There are issues of access and cost for many primary care physicians, and also of interpretation. It is probably most appropriate to discuss individual cases with an experienced gastroenterologist before embarking on further investigations of this kind.
A further subgroup of patients with typical GERD symptoms can emerge, namely those with negative endoscopy and negative pH-metry. These are best treated as non-ulcer dyspepsia, using the range of drugs currently employed for this condition, including prokinetic agents.
Patients with atypical symptoms and without alarm symptoms can often be usefully investigated with a therapeutic trial of anti-secretory drug, preferably a PPI. Patients in whom a PPI test is negative, but in whom GERD is still a likely diagnosis, should be referred for endoscopy; those in whom the PPI test is positive can reasonably be treated with empirical anti-secretory therapy with a PPI for up to eight weeks, and will then follow the same algorithmic pathway as patients in the "typical" category.
The role of Helicobacter pylori and the place of Helicobacter eradication in GERD 
LONG-TERM MANAGEMENT
The overall aim of the long-term management of patients with GERD in primary care is to ensure that patients' symptoms are controlled as fully as possible, and that their risk of complications is minimized, and also that this is achieved in a cost-effective way. In order to achieve these goals, a number of questions remain to be answered before a primary care strategy for the long-term management of GERD can be agreed upon:
1. The relative merits and disadvantages of "step down" and "step up" approaches to acid suppression. In other words is it most appropriate to begin treatment with high-dose anti-secretory therapy and to reduce the dose to the lowest level compatible with suppression of symptoms, or is it more appropriate, as traditionally recommended, to begin with simple anti-acid medication and to increase the dose until control of symptoms is achieved? There is clinical and computer modeling evidence that the former approach is more likely to be costeffective, although the findings of this modeling exercise require confirmation in a clinical trial [12, 13] .
2. Should the long-term management of GERD be exclusively symptom-led, or does endoscopy have a role in management? Given the mismatch between clinical symptoms and the endoscopic findings, it might be argued that the risk of complications (stricture formation, Barrett's esophagus, and cancer) could be reduced if patients with unhealed erosive lesions were identified and more appropriately treated.
3.. The role of anti-reflux surgery, particularly techniques involving minimally invasive approaches, needs to be clarified. It is likely that many primary care physicians regard anti-reflux surgery as a procedure that should be reserved for those who fail to respond to drug therapy. However, there is accumulating evidence that antireflux surgery represents a clinically appropriate and cost-effective alternative to long-term antiscretory therapy [14] .
In conclusion, while it is possible to sketch out a primary care strategy for the management of GERD, a number of data are still required to fill in the details. Wellconducted diagnostic and clinical trials, with robust health economics and health services components, are required to answer some of these outstanding questions
